Bibliographie (2546)
![[Not published yet] Observational study in Uruguay found CoronaVac reduced mortality by 97 percent – “In people who had received two doses, it reduced infection with the coronavirus by 57 percent and intensive care admissions by 95 percent”.](/media/k2/items/cache/0e10dc31a783038aaa2ac17353b1949b_L.jpg)
[Not published yet] Observational study in Uruguay found CoronaVac reduced mortality by 97 percent – “In people who had received two doses, it reduced infection with the coronavirus by 57 percent and intensive care admissions by 95 percent”.
lundi, 31 mai 2021 10:55 Écrit par Zouhair SouissiCoronaVac reduces mortality by 97 percent: Uruguay study – Associated Press
The post [Not published yet] Observational study in Uruguay found CoronaVac reduced mortality by 97 percent – “In people who had received two doses, it reduced infection with the coronavirus by 57 percent and intensive care admissions by 95 percent”. appeared first on Links Medicus.
Covid-19 vaccination prevents transmission from vaccinated to unvaccinated household members.
lundi, 31 mai 2021 10:55 Écrit par Zouhair SouissiThe indirect effect of mRNA-based Covid-19 vaccination on unvaccinated household members – medRxiv Related: Can people vaccinated against COVID-19 still spread the coronavirus? – “Preliminary evidence seems to suggest the COVID-19 vaccines make it less likely someone who’s vaccinated will transmit the coronavirus”. Commentary on Twitter More on less transmission, yet another incentive: "Our […]
The post Covid-19 vaccination prevents transmission from vaccinated to unvaccinated household members. appeared first on Links Medicus.
No COVID-19 cases found after a well-controlled indoor concert.
lundi, 31 mai 2021 10:55 Écrit par Zouhair SouissiNo COVID-19 cases found after well-controlled indoor concert – CIDRAP Original study: Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial – The Lancet Infectious Diseases Invited Commentary: Innovations in COVID-19 testing: the road from pandemic response to control – The Lancet Infectious Diseases Commentary on Twitter […]
The post No COVID-19 cases found after a well-controlled indoor concert. appeared first on Links Medicus.
Opinion | 7 reasons why we should not need boosters for COVID-19.
lundi, 31 mai 2021 10:55 Écrit par Zouhair Souissi7 Reasons Why We Should Not Need Boosters for COVID-19 – by Monica Ghandi, MD
The post Opinion | 7 reasons why we should not need boosters for COVID-19. appeared first on Links Medicus.
New IDSA Guidelines on antigen testing for the diagnosis of COVID-19.
lundi, 31 mai 2021 10:55 Écrit par Zouhair SouissiIDSA Guidelines on the Diagnosis of COVID-19: Antigen Testing – Infectious Diseases Society of America
The post New IDSA Guidelines on antigen testing for the diagnosis of COVID-19. appeared first on Links Medicus.
The global burden of smoking tobacco and attributable disease in 204 countries and territories – “In the absence of intervention, the annual toll of 7.69 million deaths and 200 million disability-adjusted life-years attributable to smoking will increase o
vendredi, 28 mai 2021 11:02 Écrit par Zouhair SouissiSpatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 – The Lancet News Release: The Lancet & The Lancet Public Health: Latest global data finds nearly 8 million deaths from smoking in […]
The post The global burden of smoking tobacco and attributable disease in 204 countries and territories – “In the absence of intervention, the annual toll of 7.69 million deaths and 200 million disability-adjusted life-years attributable to smoking will increase over the coming decades”. appeared first on Links Medicus.
Covid-19: Pfizer-BioNTech vaccine is “likely” responsible for deaths of some elderly patients, Norwegian review finds.
vendredi, 28 mai 2021 11:02 Écrit par Zouhair SouissiCovid-19: Pfizer-BioNTech vaccine is “likely” responsible for deaths of some elderly patients, Norwegian review finds – The BMJ Commentary on Twitter The Pfizer-BioNTech covid-19 vaccine is “likely” to have been responsible for at least 10 deaths of frail elderly people in nursing homes in Norway, an expert review concluded, although it emphasised considerable uncertainty […]
The post Covid-19: Pfizer-BioNTech vaccine is “likely” responsible for deaths of some elderly patients, Norwegian review finds. appeared first on Links Medicus.
RCT: Pfizer-BioNTech Covid-19 vaccine shows 100% efficacy in adolescents – mainly transient mild-to-moderate reactogenicity was frequently observed, such as injection-site pain (in 79 to 86% of participants), fatigue (in 60 to 66%), and headache (in 55 to
vendredi, 28 mai 2021 11:02 Écrit par Zouhair SouissiSafety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents – New England Journal of Medicine Related: [Press release – not published yet] Pfizer-BioNTech vaccine 100% effective against Covid-19 in adolescents Commentary on Twitter The 12-15 year-olds mRNA vaccine randomized, placebo-controlled clinical trial is published @NEJM today [@BioNTech_Group/@Pfizer]https://t.co/7GlgC9xdd0—100% efficacy (95% CI 75,100)—1.8 X […]
The post RCT: Pfizer-BioNTech Covid-19 vaccine shows 100% efficacy in adolescents – mainly transient mild-to-moderate reactogenicity was frequently observed, such as injection-site pain (in 79 to 86% of participants), fatigue (in 60 to 66%), and headache (in 55 to 65%). appeared first on Links Medicus.
Lab study found CoronaVac serum neutralization efficiency was significantly decreased against B.1.526, P.1, and B1.351 SARS-CoV-2 variants.
vendredi, 28 mai 2021 11:02 Écrit par Zouhair SouissiSerum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac – The Lancet Infectious Diseases
The post Lab study found CoronaVac serum neutralization efficiency was significantly decreased against B.1.526, P.1, and B1.351 SARS-CoV-2 variants. appeared first on Links Medicus.
COLCORONA RCT: Colchicine for community-treated patients with COVID-19 – findings suggest it may lower death and hospital admission rates, but further studies are required.
vendredi, 28 mai 2021 11:02 Écrit par Zouhair SouissiColchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial – The Lancet Respiratory Medicine Invited Commentary: Exploiting an early immunological window of opportunity in COVID-19 – The Lancet Respiratory Medicine
The post COLCORONA RCT: Colchicine for community-treated patients with COVID-19 – findings suggest it may lower death and hospital admission rates, but further studies are required. appeared first on Links Medicus.
![[Preprint] More data showing a single-dose SARS-CoV-2 mRNA vaccine may be enough in individuals with previous COVID-19.](/media/k2/items/cache/34881b8882798e6c95711d6bcfcd403c_XS.jpg)
